Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Combined Synopsis/Solicitation opportunity was posted on August 23, 2018. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

The Cancer Letter - Annual Institution-wide Online Subscription to Cancer Research and

Awarded
N02CO8264-36Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The National Cancer Institute is seeking a non-issued firm fixed price contract for an annual institution-wide online subscription to cancer research and drug development content. The requirement includes two primary tasks: providing 12 months of access to The Cancer Letter for 3,000 to 4,000 users and a 12-month subscription to NCI Partners. Key deliverables include weekly updates on cancer-related content, summaries of grant opportunities from the NCI and FDA, Phase III clinical trial results, and quarterly usage reports. Access must be managed via IP verification and supported by online assistance during normal business hours. The period of performance is scheduled from September 21, 2018, through September 20, 2019, with delivery required within six weeks of the award. This solicitation is open to periodical publishers under NAICS code 511120. The contract will be awarded to a single provider based on the Lowest Price Technically Acceptable criteria. All quotations must be submitted electronically to the contracting office by 12:00 PM EST on August 29, 2018.

General Info

Agency

N/A

Contract Value

$76,500

NAICS

511120 - Periodical Publishers

Place of Performance

DC, USA

Set-Aside

NONE

Award Issued Date

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

1 update
PhaseAwarded
Posted

Combined Synopsis

Notice updated

Response deadline changed from Aug 27, 2018 to Aug 29, 2018. The notice description changed. The point of contact changed.

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts2 people available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
David H. RomleyContract Specialist
Reyes RodriguezContracting Officer

Full Description

Show more
The purpose of this amendment is to extend the response date to Wednesday, August 29, 2018 at 12:00PM EST. Title: The Cancer Letter - Annual Institution-wide Online Subscription to Cancer Research and Drug Development Content Document Type: Combined Synopsis / Solicitation Notice Solicitation Number: N02CO8264-36 Proposed Posted Date: 8/16/2018 Proposed Response Date: 8/29/18 Classification Code: T - Photographic, Mapping, Printing, and Publications NAICS Code: 511120 - Periodical Publishers Business Size Standard: 1000 Employees Contracting Office Address Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Room 1E122, Bethesda, MD 20892, UNITED STATES. Non-USPS mail such as Fedex UPS and other private carriers please use Rockville, MD 20850. The National Cancer Institute (NCI), Office of Communications and Public Liaison (OCPL), would like to procure an annual institution-wide online subscription to cancer research and drug development content. This is a combined synopsis/solicitation for commercial items, prepared in accordance with format in FAR 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation and a separate written solicitation will not be issued. This solicitation: No. N02CO8264-36 includes all applicable provisions and clauses in effect through FAR FAC 2005-99-1 (JUL 2018) simplified procedures for commercial items. The North American Industry Classification System code is 511120 and the business size standard is 1000 employees. Only one award will be made as a result of this solicitation. This will be awarded as a non-issued firm fixed price type contract. I. Description of Requirement The following product features/characteristics are required. The information must be presented in a newsletter format with new and updated information on a weekly basis: 4.1.0 Task 1: Cancer Letter Requirements 1.1.1 12 - months of access 1.1.2 The period of performance shall be September 21, 2018 through September 20, 2019. 1.1.3 Access for 3,000 - 4,000 users 1.1.4 24/7 timely, Quality Access of current and archived cancer content. 1.1.5 Online support shall be available during normal business hours of operation (Mon - Fri) 8am - 5pm EST. 1.1.6 Confirmation of each NCI online user access setup. 1.1.7 Quarterly report of active or inactive users, including: Unique Visitors The Number of Visits Page Views 1.1.8 IP verification for access instead of username/password 1.1.9 Weekly updates to cancer-related content 1.1.10 Listing of cancer research funding opportunities 1.1.11 Summarization of NCI grant opportunities and awards 1.1.12 Summarization of FDA grant opportunities and awards 1.1.13 Summarization of Rare Disease drug designations 1.1.14 Presentation of legislative issues surrounding cancer research and funding 1.1.15 Summarization of FDA approved cancer drugs 1.1.16 Listing and summary of NCI approved trials - monthly 1.1.17 Summary of cancer related industry trials 1.1.18 Detailed summary of Phase III clinical trial results 1.1.19 Downloadable PDF versions of weekly content 1.1.20 Bonus access to clinical trial information 4.2.0 Task 2: NCI Partners (NCORP) 4.2.1 12-month subscription access to NCI Partners (NCORP) 4.2.2 Vendor shall contact NCI/DCP POC contact (Worta McCaskill-Stevens) to obtain The NCORP list of NCI Partners 4.2.3 Vendor shall obtain IP addresses from NCI/DCP POC 4.2.4 IP verification for access instead of username/password to NCI Partners (NCORP) 4.2.5 Weekly updates to cancer-related content 4.2.6 Listing of cancer research funding opportunities 4.2.7 Provide online support shall be available during normal business hours of operation (Mon-Fri) 8am - 5pm EST II. Delivery: Contractor shall deliver the item(s) within 6 weeks after award to: NIH/NCI Bethesda, Maryland 20892. The Contractor that receives the award will be provided with the complete mailing address and point of contact. Upon award, contractor must notify the NCI Technical Point of Contact to schedule the delivery. III. Payment: Payment shall be made after delivery and acceptance by the Technical Point of Contact. Payment authorization requires submission and approval of invoice by the NCI COR and NIH Commercial Accounts. QUESTIONS ARE DUE: August 21, 2018 The purchase order will be awarded to the Lowest Price Technically Acceptable (LPTA). The award will be made on the basis of the lowest evaluated price of quotations meeting or exceeding the acceptability standards for the requirements/technical specifications stated above. The technical evaluation will be a determination based on information furnished by the vendor. The Government is not responsible for locating or securing any information which is not identified in the quote. The Government reserves the right to make an award without discussions. PROVISIONS AND CLAUSES: The following FAR provisions and clauses apply to this acquisition: 52.212-1 Instructions to Offerors Commercial Items (Jan 2017); 52.212-2 Evaluation Commercial Items (OCT 2014): FAR clause 52.212-3 OFFEROR REPRESENTATIONS AND CERTIFICATIONS-COMMERCIAL ITEMS- (Nov 2017) WITH DUNS NUMBER ADDENDUM {52.204-6 (Oct 2016)}; FAR Clause 52.212-4 CONTRACT TERMS AND CONDITIONS - COMMERCIAL ITEMS (Jan 2017); FAR Clause 52.212-5: CONTRACT TERMS AND CONDITIONS REQUIRED TO IMPLEMENT STATUTES OR EXECUTIVE ORDERS-COMMERCIAL ITEMS (Jul 2018). The following FAR clauses cited in paragraph (b) of the clause at FAR 52.212-5 are also applicable to this acquisition; FAR Clause 52.203-6, Restrictions on Subcontractor Sales to the Government (Sept 2006) FAR Clause 52.204-10, Reporting Executive Compensation and First-Tier Subcontract Awards (Oct 2016) FAR Clause 52.209-6, Protecting the Government's Interest When Subcontracting with Contractors Debarred, Suspended, or Proposed for Debarment. (Oct 2015) FAR Clause 52.219-4, Notice of Price Evaluation Preference for HUBZone Small Business Concerns (Oct 2014) FAR Clause 52.219-6, Notice of Total Small Business Aside (Nov 2011) (15 U.S.C. 644) FAR Clause 52.219-28, Post Award Small Business Program Representation (Jul 2013) FAR Clause 52.222-3, Convict Labor (June 2003) FAR Clause 52.222-19, Child Labor-Cooperation with Authorities and Remedies (Jan 2018) FAR Clause 52.222-21, Prohibition of Segregated Facilities (Apr 2015) FAR Clause 52.222-26, Equal Opportunity (Sep 2016) FAR Clause 52.222-35, Equal Opportunity for Veterans (Oct 2015) FAR Clause 52.222-36, Equal Opportunity for Workers with Disabilities (Jul 2014) FAR Clause 52.222-37, Employment Reports on Veterans (Feb 2016) FAR Clause 52.222-40, Notification of Employee Rights Under the National Labor Relations Act (Dec 2010) FAR Clause 52.223-18, Encouraging Contractor Policies to Ban Text Messaging While Driving (AUG 2011) FAR Clause 52.225-1, Buy American Act--Supplies (May 2014) FAR Clause 52.225-3, Buy American-Free Trade Agreements-Israeli Trade Act (May 2014) Alternate II (May 2014) of 52.225-3 FAR Clause 52.225-13, Restrictions on Certain Foreign Purchases (June 2008) FAR Clause 52.232-33, Payment by Electronic Funds Transfer-System for Award Management (Jul 2013) Full text copies of the representations and certifications for other cited provisions and clauses may be obtained online at the NCI website at http://ncioa.cancer.gov/oa-internet/ or from David Romley, Contract Specialist at contact@example.gov OFFERORS: Offers must be submitted on an SF-1449 with a completed 52.212-3 Offeror Representations and Certifications-Commercial Items-with DUNS Number Addendum, signed by an authorized representative of the offeror OR provide a copy of the valid certification registrations of the offeror's Central Contractor Registration (CCR) and Online Representations and Certifications Applications (ORCA) through www.sam.gov. Quotations must be received in the NCI-OA contracting office by 12:00 p.m. EST on August 29, 2018. Please refer to solicitation number N02CO8264-36 on all correspondence. Faxed quotations will NOT be accepted. Quotations may be submitted via email to David Romley, Contract Specialist at contact@example.gov. All questions shall be in writing and may be addressed to the aforementioned individual noted above. In order to receive an award, contractors must be registered and have valid certification in the System for Award Management through sam.gov.

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS